Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.58 |
| ▸ | CALCR | P30988 | 9/20 | 0.53 |
| ▸ | NMBR | P28336 | 2/20 | 0.51 |
| ▸ | GRPR | P30550 | 2/20 | 0.51 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.50 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.50 |
| ▸ | MC4R | P32245 | 1/20 | 0.48 |
| ▸ | RAMP3 | O60896 | 5/20 | 0.48 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30898604 | 0.94 | F2 (0.58) | F2CALCRMC4RRAMP3 | |
| SCHEMBL30658564 | 0.89 | F2 (0.58) | F2CALCRNMBRGRPRHCRTR1 | |
| SCHEMBL29674857 | 0.88 | F2 (0.52) | F2CALCRCRHR1CRHR2 | |
| SCHEMBL29865880 | 0.88 | CALCR (0.57) | F2CALCRNMBRGRPRHCRTR1 | |
| SCHEMBL31453820 | 0.87 | F2 (0.55) | F2CALCRNMBRGRPRHCRTR1 | |
| SCHEMBL30978825 | 0.87 | BACE1 (0.50) | F2CALCRRAMP3 | |
| SCHEMBL30723555 | 0.87 | F2 (0.56) | F2CALCRRAMP3 | |
| SCHEMBL31031589 | 0.86 | F2 (0.61) | F2CALCRHCRTR1HCRTR2MC4R | |
| SCHEMBL29446768 | 0.85 | CALCR (0.58) | F2CALCRNMBRGRPRRAMP3 | |
| SCHEMBL31453812 | 0.85 | F2 (0.67) | F2CALCRNMBRGRPRHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118063583-A | Casein antibacterial peptide or composition and application thereof | 中国科学院大连化学物理研究所 | 2024-05-24 | — | — | CN | disclosed |